Clinical Trial Update: Resveratol in Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Resveratol for diabetic nephropathy sponsored by Ain Shams University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Resveratol (Resveratrol)

Snippet

Sponsor: Ain Shams University | Conditions: Type 1 Diabetic Nephropathy | Phase 2, Phase 3 | Status: COMPLETED